Bone Therapeutics(GB:0R55)
€0.010.00 (0.00%)
GB:0R55
Bone Therapeutics financials statements
€0.01
At close:0.00 (0.00%)
Bone Therapeutics (0R55) Income Statement
2 Followers
Bone Therapeutics Income Statement
Last quarter (Q4 2025), Bone Therapeutics's total revenue was €0.00, a decrease of 100.00% from the same quarter last year. In Q4, Bone Therapeutics's net income was €21.64M. See Bone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 0.00 | € 0.00 | € 543.00K | € 296.00K | € 312.00K | |
| € 0.00 | € -196.00K | € 543.00K | € 296.00K | € 987.00K | |
| € 1.32M | € 8.08M | € 7.38M | € 2.52M | € 1.18M | |
| Depreciation and Amortization | € 0.00 | € 196.00K | € 243.00K | € 60.00K | € 13.00K |
| € -1.32M | € -4.84M | € -6.80M | € -2.26M | € -864.00K | |
| € -1.32M | € -8.27M | € -7.04M | € -2.32M | € -1.19M | |
| € 22.26M | € 1.56M | € -21.99M | € -731.00K | € 205.00K | |
| € 20.93M | € -6.71M | € -29.03M | € -3.05M | € -984.00K | |
| € 20.93M | € -4.77M | € -28.78M | € -2.04M | € -984.00K | |
| Per Share Metrics | |||||
| Basic EPS | € 0.03 | € -0.02 | € -0.21 | € -0.02 | € -0.05 |
| Diluted EPS | € 0.03 | € -0.02 | € -0.21 | € -0.02 | € -0.05 |
| Weighted Average Shares Outstanding | 652.86M | 231.34M | 137.04M | 120.13M | 21.31M |
| Weighted Average Shares Outstanding (Diluted) | 652.86M | 231.34M | 137.04M | 120.13M | 21.31M |
Currency in EUR
